BioTech Annecto Montreal is pleased to announce a presentation given Luca Genovesi, PhD, Principal Scientist, at Biotrial entitled:
Bioanalytical method validation in drug development: CRO perspective
Bioanalytical method validation employed for the quantitative determination of drugs and their metabolites concentration in biological fluids plays a significant role in the drug development and it’s strictly regulated by different agencies across the globe. This presentation provides a quick glance at the pathway that a new drug needs to follow to enter in to the market. Particular focus will be given to the quantitation of small molecules and biologics in different stage of drug development. Samples preparation and analytical techniques will be illustrated to understand the complex work that is behind a CRO business.
Luca is a Principal Scientist at Biotrial dedicated to LC-MS Large Molecule quantitation, within the Method Development Group. He obtained his PhD in Industrial Biotechnology at the University of Milano Bicocca (Milan, Italy) with a focus in mass spectrometry. Before joining Biotrial Pharma, Luca was Senior Scientist and Technical leader both in pharmaceutical industry as well as different CROs. Luca has more than ten years of experience in protein mass spectrometry. He is also content administrator for the CRO focus group within the American Association of Pharmaceutical Science.
Who is invited?
Professionals in the following industries: pharmaceuticals, CROs, biotechnology, and medical technology, Health care and biomedical research
People seeking opportunities to enlarge their professional network in life science industries.
When and Where?
6:30pm to 9pm on Tuesday June 19, 2018
Pub L’île Noire
1649 rue St-Denis
Cost: $15 (up to 48h before the event) / $20 regular price / FREE if you purchase a yearly membership
Please login to the site, using LinkedIn preferably, to be able to register for the event.